The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting
The lack of core outcome sets for atopic eczema (AE) is a major obstacle for advancing evidence-base...
Background: Recap of atopic eczema (RECAP) is a patient-reported outcome measure assessing eczema co...
The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a ...
Research comparing the effectiveness of different eczema treatments is limited by inconsistency in b...
Atopic eczema (herein referred to as ‘eczema’) is a skin disease characterized by remitting and rela...
Atopic eczema (herein referred to as ‘eczema’) is a skin disease characterized by remitting and rela...
BackgroundEczema control has been identified as an important outcome by key stakeholders in eczema r...
Background: Eczema control has been identified as an important outcome by key stakeholders in eczema...
Background Eczema control has been identified as an important outcome by key stakeholders in eczema ...
Background: Eczema control has been identified as an important outcome by key stakeholders in eczema...
Importance: Measuring outcomes in clinical practice can aid patient care, quality improvement, and r...
Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring pati...
BackgroundRecap of atopic eczema (RECAP) is a patient-reported outcome measure (PROM) assessing ecze...
The lack of core outcome sets for atopic eczema (AE) is a major obstacle for advancing evidence-base...
Background: Recap of atopic eczema (RECAP) is a patient-reported outcome measure assessing eczema co...
The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a ...
Research comparing the effectiveness of different eczema treatments is limited by inconsistency in b...
Atopic eczema (herein referred to as ‘eczema’) is a skin disease characterized by remitting and rela...
Atopic eczema (herein referred to as ‘eczema’) is a skin disease characterized by remitting and rela...
BackgroundEczema control has been identified as an important outcome by key stakeholders in eczema r...
Background: Eczema control has been identified as an important outcome by key stakeholders in eczema...
Background Eczema control has been identified as an important outcome by key stakeholders in eczema ...
Background: Eczema control has been identified as an important outcome by key stakeholders in eczema...
Importance: Measuring outcomes in clinical practice can aid patient care, quality improvement, and r...
Background: Measuring patient-centered outcomes in clinical practice is valuable for monitoring pati...
BackgroundRecap of atopic eczema (RECAP) is a patient-reported outcome measure (PROM) assessing ecze...
The lack of core outcome sets for atopic eczema (AE) is a major obstacle for advancing evidence-base...
Background: Recap of atopic eczema (RECAP) is a patient-reported outcome measure assessing eczema co...
The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a ...